What is the forecast for Cencora?
Equity research analysts tracking Cencora, Inc. (COR) maintain a consensus Buy rating, with average 12-month price targets clustering around $350.58 to $357.00 per share, and upper estimates reaching up to $374.00. Valuation frameworks incorporate steady revenue growth across pharmaceutical distribution channels, robust return on equity metrics, specialty logistics expansions, and efficient capital allocation strategies featuring conservative payout ratios and strategic share repurchase initiatives.
Related FAQs
The Cencora security incident refers to a major data breach and cyberattack involving unauthorized exfiltration of sensitive consumer and corporate data from the pharmaceutical solutions and drug wholesale enterprise.
Wall Street equity analysts generally maintain a favorable buy or moderate accumulation consensus rating for Cencora, one of the world's leading global healthcare solutions and pharmaceutical distribution enterprises.
Equities that historically demonstrate resilience or defensive outperformance during broad market crashes typically belong to non-cyclical sectors such as consumer staples, utilities, healthcare, and discount retail.
Cencora, a massive American multinational drug wholesale corporation and pharmaceutical services provider, operated under the corporate name AmerisourceBergen Corporation prior to its comprehensive global rebrand.
Someone can potentially access your bank account using your physical debit card if they also possess your Personal Identification Number or if they use the card for unauthorized contactless or online transactions that do not strictly require a PIN.
Cencora, Inc.
Legal and financial settlements involving Cencora, formerly known as AmerisourceBergen, typically relate to comprehensive multi-state and federal litigation concerning opioid distribution practices and regulatory compliance frameworks.
Union members who leave their jobs or quit before reaching retirement age do not necessarily lose their pension benefits, provided they have met the plan's vesting requirements.
Centene Corporation demonstrates solid operational and financial performance, anchoring its market position as a leading healthcare enterprise focusing on government-sponsored healthcare programs, including Medicaid, Medicare, and the Health Insuranc...
Cencora, Inc. (formerly known as AmerisourceBergen), a global leader in pharmaceutical sourcing, distribution, and clinical service solutions, is headquartered in Conshohocken, Pennsylvania, United States.
Under class-action data breach settlement terms related to Cencora incidents, participating class members can submit claims for documented out-of-pocket losses, receiving reimbursement up to $5,000 per person for verified unreimbursed expenses or los...
When purchasing standard, non-leveraged, long positions in Bitcoin on eToro using cash balances, investors are investing in the underlying asset, meaning the platform purchases and holds the actual tokens on their behalf in a secure omnibus wallet.
Coromandel International Limited, a prominent player in the agricultural solutions, phosphatic fertilizers, and crop protection sector, follows a consistent annual dividend distribution policy.
Cencora officially ranks as a top-tier Fortune 10 company, securing a prestigious position among the absolute largest corporations in the United States by total annual revenue.
Cencora (formerly AmerisourceBergen) is a massive global healthcare solutions company and pharmaceutical wholesale distributor that manages a comprehensive portfolio of subsidiary enterprises.
Legal settlements and class-action notices associated with Cencora (formerly AmerisourceBergen) regarding corporate data security incidents or regulatory compliance matters are entirely legitimate legal developments.
A single share of EPR Properties (NYSE: EPR) trades at approximately $63.53 USD.
Cencora is widely regarded as an exceptional, highly reputable enterprise that plays a critical role in global healthcare by distributing life-saving medications, medical products, and digital healthcare solutions safely across international markets.